OBJECTIVE: To test the hypothesis whether herbal medicines ameliorate inflammatory diseases via the modulation of cellular adhesion molecules (CAMs). METHODS: Human neutrophils, synovial fibroblasts, and endothelial cells were incubated with different concentrations of Tripterygium Wilfordii Hook-f (TWH-f) or Tetrandrine in the presence or absence of interleukin 1 (IL1). The amount of soluble E-selectin, intercellular adhesion molecule-1 (ICAM-1) and vascular cellular adhesion molecule-1 (VCAM-1) secreted by cells were determined by ELISA. The cell surface expression of these three CAMs was detected by flow cytometry. RESULTS: TWH-f at high concentration (50 ng/ml) has a significant (p<0.05) inhibitory effect on both the secretion and the expression of the cellular adhesion molecules. However, Tetrandrine did not demonstrate the same effects. CONCLUSIONS: The cellular adhesion molecules of the endothelium and leucocytes may constitute excellent targets for the development of new anti-inflammation medicines. These results indicate that TWH could be a potential therapeutic agent in the treatment of inflammatory diseases.
OBJECTIVE: To test the hypothesis whether herbal medicines ameliorate inflammatory diseases via the modulation of cellular adhesion molecules (CAMs). METHODS:Human neutrophils, synovial fibroblasts, and endothelial cells were incubated with different concentrations of Tripterygium Wilfordii Hook-f (TWH-f) or Tetrandrine in the presence or absence of interleukin 1 (IL1). The amount of soluble E-selectin, intercellular adhesion molecule-1 (ICAM-1) and vascular cellular adhesion molecule-1 (VCAM-1) secreted by cells were determined by ELISA. The cell surface expression of these three CAMs was detected by flow cytometry. RESULTS:TWH-f at high concentration (50 ng/ml) has a significant (p<0.05) inhibitory effect on both the secretion and the expression of the cellular adhesion molecules. However, Tetrandrine did not demonstrate the same effects. CONCLUSIONS: The cellular adhesion molecules of the endothelium and leucocytes may constitute excellent targets for the development of new anti-inflammation medicines. These results indicate that TWH could be a potential therapeutic agent in the treatment of inflammatory diseases.
Authors: Samantha Landreth; April M Teague; Mary E Jensen; Shelly Gulati; Jeanie B Tryggestad Journal: Nutr Metab Cardiovasc Dis Date: 2022-02-10 Impact factor: 4.222
Authors: Carmelita G Frondoza; Afshin Sohrabi; Anna Polotsky; Phong V Phan; David S Hungerford; Lars Lindmark Journal: In Vitro Cell Dev Biol Anim Date: 2004 Mar-Apr Impact factor: 2.416
Authors: Salahuddin Ahmed; Jeremy Anuntiyo; Charles J Malemud; Tariq M Haqqi Journal: Evid Based Complement Alternat Med Date: 2005-09 Impact factor: 2.629
Authors: Beatrix Péter; Imre Boldizsár; Gábor M Kovács; Anna Erdei; Zsuzsa Bajtay; Alexandra Vörös; Jeremy J Ramsden; Ildikó Szabó; Szilvia Bősze; Robert Horvath Journal: Biomedicines Date: 2021-11-26